Weighty issue: How to contain GLP-1 costs
Get strategies for handling the new anti-obesity medications.
How to manage the most talked-about drugs in all of pharmacy
New anti-obesity medications are effective but expensive and more than half of U.S. adults are eligible for them. Members who reach a healthier weight are less likely to have other health complications, so it’s great for the long run. But what about right now?
Plan sponsors need a game plan to balance the need for these drugs and contain the costs in their benefit plans.
Related content
2024: A new year promises a host of new drugs
See which trends to consider when assessing the pharmacy benefit, which new drugs may be flying under the radar and what’s coming this year.
How to manage blockbuster anti-obesity drugs
The pricey weight management drugs work well, but users need coaching and support to maintain the benefits.
GLP-1 agonists: A new class of weight loss medications
In this conversation, discover how new weight loss drugs like Wegovy are changing obesity management and their connection to diabetes.